Articles tagged with Vaccination
A new study models the impact of MMR vaccination strategies on measles outbreaks in Texas, highlighting the critical role of improving immunization rates. The findings suggest that increasing vaccine coverage can significantly reduce the risk of large-scale measles outbreaks.
Ensemble projections suggest vaccinating high-risk groups reduces disease burden, while broader vaccine availability saves more lives. Averted COVID-19 burden due to vaccination is robust across immune escape scenarios.
Scientists found that stretching the skin stimulates immune cells and increases its ability to absorb large molecules, including vaccines. This approach resulted in higher antibody levels against the H1N1 flu antigen compared to traditional needle-free delivery methods.
The report makes recommendations for diagnosing, treating and preventing serious heart and blood vessel complications linked to the virus. Structured cardiac rehabilitation programmes are also recommended to prevent long-term problems after infection and aid recovery from long Covid.
A recent Annenberg Public Policy Center survey found that 70% of the public supports vaccine requirements for MMR in schools. The percentage increased from 63% in August 2023. The survey also showed that over 7 in 10 U.S. adults support a policy making it mandatory for parents to vaccinate their children against preventable diseases.
Researchers analyzed multiple countries' performance in achieving infection control and economic recovery, highlighting the impact of risk attitudes, patience, and trust on policy decisions. Countries with high levels of trust and patience managed to limit deaths and resuming production, while those with low trust and higher risk toler...
Researchers found that correcting myths with facts strengthened people's intentions to get vaccinated, making myth-busting strategies a key to broader vaccine distribution. The study suggests three effective strategies for debunking false information about COVID vaccines.
Scientists from La Trobe University and Kumamoto University have identified an internal protein particle hidden within the SARS-CoV-2 virus, which can trigger a strong immune response in killer T cells.
A study published in JAMA found that one shot of an RSV vaccine protects adults ages 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons. The vaccine reduced the risk of hospitalization by 58% overall, with a higher reduction seen in the first year after vaccination.
A new global systematic literature review and meta-analysis found a significant association between herpes zoster vaccination and reduced risk of heart attack and stroke. Vaccination was linked to an 18% and 16% reduction in cardiovascular events for adults 18 and 50 years old, respectively.
A recent study found a sharp increase in hospitalisations for pertussis among children and adolescents in Tuscany, Italy, between 2016 and 2024. The study emphasizes the critical role of timely vaccination administration to prevent further cases and hospitalisations.
A comprehensive epidemiological study found that people who had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma and chronic sinusitis. Vaccination against SARS-CoV-2 virus appears to reduce this risk.
A recent study reveals woefully low awareness of human papillomavirus (HPV), the HPV vaccine, and their association with cancer in the Midwestern and Southern US states. These states have seen a rise in HPV-associated cancers, making suboptimal HPV vaccination rates even more alarming.
A new study by Michigan Medicine University of Michigan researchers concludes that broad COVID-19 vaccination in adults saves the US more money than it spends, with significant economic benefits for those over 65 and middle-aged adults. The model focuses on preventing deaths, hospitalizations, and lost productivity.
This book delves into the scientific foundations of mucosal vaccine platforms, discussing immunological mechanisms, novel adjuvants, and real-world development challenges. It serves as a valuable resource for professionals and students in life sciences, immunology, and pharmacology.
Adults with long COVID experience worse work impairment, missed work, and financial distress compared to those without long COVID. Vaccination is associated with improved work outcomes and reduced financial distress among individuals with long COVID.
A national study calls for increased vaccine screening in emergency departments to address health inequities. The study found that nearly a third of the US population lacks primary care access and rarely receives vaccination screenings.
A new study found that nearly nine in ten emergency department patients have not received one or more recommended vaccines. This reveals significant gaps in preventive care among underserved populations, who often rely on emergency departments for healthcare.
A survey of over 1,600 US adults found that most know the negative impacts of smoking and drinking during pregnancy, but uncertainty exists around vaccines and weight gain recommendations. The majority are unsure about recommended vaccines for pregnant individuals, with a notable drop in knowledge since last year.
A nationwide cohort study of 1 million adults found no increased risk of 29 adverse events after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage. The study provides reassuring safety data on the new vaccine, which has been widely adopted in response to the Omicron variant
Researchers have demonstrated a novel vaccine delivery method using dental floss, which stimulates the production of antibodies in mucosal surfaces, such as the lining of the nose and lungs. This technique has shown superior antibody response compared to current oral vaccination methods.
Researchers at Penn State and WHO develop a method to predict regional measles vaccination coverage even without accurate survey data. The method uses routinely collected data on potential measles cases, resulting in highly correlated predictions with gold-standard DHS data.
Researchers found a significant link between vaccination of pregnant women and a drop in newborns being admitted to hospital with a serious lung infection. The RSV vaccine offered a 72% reduction in hospital admissions, with mothers who received the jab before delivery having twice the protective effect.
This study uses an analytical model to examine the effects of influenza vaccination on both vaccinated and unvaccinated populations. The results show that vaccination provides significant reductions in disease burden, even when vaccine effectiveness is low, but these benefits are limited in high transmission situations.
A review led by Oregon Health & Science University researchers suggests that the US could save $1 billion a year by dropping adult tetanus and diphtheria booster shots if childhood vaccination rates remain strong. The safety of this approach depends on maintaining high childhood vaccination coverage.
Researchers found that the H5N1 virus enters the mammary glands through the teat, not via respiratory infection. Lactating cows' self-nursing or mutual-nursing behaviors may facilitate this transmission. Vaccination with two different vaccines showed complete protection against H5N1 infection in cattle.
A nationwide Danish cohort study found no evidence linking cumulative aluminum exposure from early childhood vaccination to autoimmune, atopic, or neurodevelopmental disorders. The study followed over 1.2 million children and used national health registries to track their aluminum exposure and chronic disorder development.
A Danish study finds that HPV vaccination has reduced prevalence of high-risk HPV types among vaccinated women, suggesting population immunity. However, non-vaccine types remain common and new infections occur more frequently in vaccinated women than unvaccinated women.
A community-based pneumococcal vaccination support program in Sera Town, Japan, reduced pneumonia-related mortality by 25% among the elderly. The program reversed a previously increasing trend in pneumonia mortality rate in the community.
A new ESC Clinical Consensus Statement highlights vaccination as a crucial preventive strategy for reducing cardiovascular events following viral and bacterial infections. Vaccines are recommended for patients with chronic coronary syndromes and heart failure, particularly those at increased risk due to underlying medical conditions.
A new poll by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation found that most U.S. adults (79%) support routine childhood vaccine requirements to attend school, including a majority across party lines. The vast majority of parents and adults believe vaccines are safe for most children.
Despite decades of progress, global immunization targets are unlikely to be met due to stagnant childhood vaccination rates and inequality. The COVID-19 pandemic has further exacerbated the issue, with widespread vaccine misinformation and hesitancy contributing to faltering immunization progress.
Researchers identified six overexpressed and mutated tumor antigens strongly associated with poor prognosis in esophageal cancer. The study's findings suggest BTN2A1, MICA, and HHLA2 as promising targets for anti-ESCA mRNA vaccines.
Researchers found associations between influenza A infection, disrupted gut and nasal microbiomes, and detrimental changes in hippocampal gene expression. Maternal vaccination during pregnancy appeared to offer protection from these changes.
The University of Texas Health Science Center at San Antonio is targeting hard-to-treat cancers and boosting HPV vaccination rates with a $3.4 million funding from CPRIT. The institution will expand its core facilities laboratories to increase researchers' ability to identify therapeutic targets and develop new cancer technologies.
The FDA has recommended pausing the use of a live attenuated chikungunya virus vaccine over concerns about safety. The vaccine was previously approved for emergency use in areas with outbreaks.
A new mRNA vaccine has shown to be more effective and less costly to develop, inducing a robust immune response against SARS-CoV-2 variants. The vaccine's trans-amplifying platform allows for reduced production costs and potential broad protection.
A nationwide decline in MMR vaccination rates among US children was confirmed by a new dataset, with significant variations observed across states and counties. The study provides valuable insights into factors influencing low vaccination rates and can inform targeted strategies to reduce measles outbreaks.
A systematic review found that vaccinating children as early as four months of age for measles could provide sustained protection throughout infancy. However, several barriers exist, including cost-effectiveness and vaccine hesitancy, which need to be addressed to consider an earlier first dose.
A study by researchers at the University of Arizona Health Sciences found that vaccinated people generated an overall protective immune response to Delta and Omicron strains, with slightly fewer antibodies for the mutated parts of the virus. The research suggests that immune changes due to antigenic imprinting may not be a significant ...
Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs. The study found that the main sources of costs were repeated visits to primary care physicians and parents missing work to care for their sick children, with higher costs for infants under 1 year old.
A recent survey found that over 83% of Americans believe the benefits of the MMR vaccine for children outweigh the risks, despite a current measles outbreak. The survey also showed that vaccination rates are dropping and many people lack knowledge about measles symptoms and prevention.
A national study in Sweden reveals that COVID-19 vaccination levels among older people have become increasingly uneven, with regional and socio-economic differences emerging. The study found lower vaccination rates among certain groups, including those born outside Sweden, men, and individuals with low income and education.
MIT researchers develop polymer microparticles that release vaccine doses at predetermined times after injection, reducing the need for follow-up shots. The particles showed comparable antibody levels to traditional vaccines in mice, paving the way for potential childhood vaccines with fewer doses.
The RSV protein subunit vaccine showed similar efficacy to clinical trials, with diminished immune response in immunocompromised patients. The vaccine was associated with a small increased risk of Guillain-Barré syndrome, but not immune thrombocytopenic purpura.
The study found that mRNA-1083 induced higher immune responses than standard care influenza and COVID-19 vaccines, with an acceptable tolerability and safety profile. The vaccine met noninferiority criteria for all 4 influenza strains and SARS-CoV-2 across various age groups.
A study of over a million people found that shingles vaccination lowers the risk of cardiovascular events, including stroke and coronary heart disease, by up to 26%. The vaccine's protective effect lasts for up to eight years, with strongest benefits in younger people and men.
Anal cancer is increasing rapidly among older, white and Hispanic women due to HPV vaccination delays. The study found a significant increase in anal cancer rates for these groups, reaching 11.4 cases per 100,000 in 2021.
A cohort study found that vaccination against influenza alone or with COVID-19 was associated with a small but temporary change in menstrual cycle length. This finding may help clinicians confirm the utility of vaccination for patients concerned about menstrual side effects.
The review highlights the limitations of existing dengue vaccines, such as CYD-TDV and TAK-003, and the urgent need for more effective vaccines to protect millions of people. The Butantan-DV vaccine has shown promise with its single-dose regimen, but its efficacy against DENV-3 and DENV-4 is still unclear.
Research reveals inequalities in MMR vaccination that may contribute to measles outbreaks and epidemics. In France, vaccines were dispensed later for children from low-income families, while a UK investigation found that deprived communities and some ethnic groups were more affected by the outbreak and less likely to be vaccinated.
The European Centre for Disease Prevention and Control (ECDC) emphasizes the need for high immunization coverage to protect European populations from diseases like measles and polio. Vaccination remains a crucial tool in public health, with recent data showing a tenfold surge in reported measles cases in the EU/EEA.
A modeling study predicts declining childhood vaccination rates will increase outbreaks of vaccine-preventable infections, leading to their reemergence. Measles is likely to be the first disease to return to endemic levels, even under current vaccination levels.
Researchers investigated the potential link between herpes zoster vaccination and dementia. They found that vaccination may be associated with a lower risk of developing dementia in older adults. The study's findings suggest a possible causal relationship between vaccination and reduced dementia occurrence.
Researchers found that B cells guide CD8 T cells to mount lasting defenses after vaccination, but their absence weakens immunity. The discovery could lead to new strategies to enhance vaccine effectiveness for those with compromised immune systems.
Measles vaccination is deemed essential for preventing serious complications, including hospitalization and death. The risk of complications is particularly high in children under 5 years old and those under 1 year old, highlighting the importance of timely vaccination.
Researchers found that full-genome differences between rotavirus strains influence vaccine effectiveness, highlighting the need for a broader approach to vaccine design. The study's results suggest that vaccines should be designed based on the whole genome of circulating strains, rather than just two surface proteins.
A new study published in Nature found that the shingles vaccine may lower dementia risk by 20%, with researchers analyzing health records of over 280,000 older adults in Wales. The vaccine was shown to reduce the occurrence of shingles by 37% and is considered a promising preventive intervention for dementia.
A cross-sectional study found that hospitalized adults with RSV vaccine eligibility were more likely to receive the vaccine. Sociodemographic differences in vaccine uptake occurred, suggesting appropriate prioritization of populations with increased risk.
Researchers from La Jolla Institute for Immunology and UC San Diego discover Zika virus blocks dendritic cells' ability to alert T cells, while dengue virus stimulates pro-inflammatory cytokines, leading to a stronger but uncontrolled immune response. Understanding these differences is key to developing life-saving vaccines.